ARCHIVES

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

This article is from The Cancer Letter archive.

Vol. 25 No. 20 | May 21, 1999

Download PDF Visit The Full Archive

Related Articles

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

November 29, 2013

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

September 5, 1980

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

December 12, 2003

No Site Visit For Georgetown Lombardi as Federal Government Shuts Down

October 4, 2013

New Tenure Program Begins, NIH May Have 20-30 Positions Open

August 5, 1994

NCI To Slow New Center Development To Assure Funding For Existing Commitments, King Says

February 14, 1975